Loading...
 
 26510 99294
 Λεωφόρος Σταύρου Νιάρχου, 455 00 Ιωάννινα
 

Η Κλινική

Δημοσιεύσεις

188 Αντικείμενα. Σελίδα 1/10
1 2 3 4 5 6 7 8 9 10
 
Δημοσιεύσεις ανά σελίδα:

1. Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study.

NPJ Prim Care Respir Med. 28 Oct 2019;29(1):38.
PMID: 31659161 [Pubmed - in process]

+ Εμφάνιση Περίληψης

2. Evaluation of exacerbations and blood eosinophils in UK and US COPD populations.

Respir Res. 07 Aug 2019;20(1):178.
PMID: 31391053 [Pubmed - in process]

3. Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long-acting bronchodilator-naïve COPD patients: A pooled analysis.

Respirology. 24 Jul 2019;[Epub ahead of print]
PMID: 31339215 [Pubmed - as supplied by publisher]

4. Diagnostic accuracy of T2 biomarkers for the prediction of airway eosinophilia in treated smoking asthmatic patients with loss of asthma control.

J Allergy Clin Immunol Pract. 13 Jun 2019;[Epub ahead of print]
PMID: 31257188 [Pubmed - as supplied by publisher]

5. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study.

Int J Chron Obstruct Pulmon Dis. 2019;14:995-1008.
PMID: 31190785 [Pubmed - in process]

6. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population.

Int J Chron Obstruct Pulmon Dis. 2019;14:853-861.
PMID: 31114183 [Pubmed - in process]

7. Differences in COPD Exacerbation Risk Between Women and Men: Analysis From the UK Clinical Practice Research Datalink Data.

Chest. Oct 2019;156(4):674-684.
PMID: 31103696 [Pubmed - in process]

8. Asthma-chronic obstructive pulmonary disease overlap: Diagnostic stability and inflammatory characteristics.

Allergy. Nov 2019;74(11):2271-2273.
PMID: 31077386 [Pubmed - in process]

9. Stability of the Blood Eosinophilic Phenotype in Stable and Exacerbated COPD.

Chest. Sep 2019;156(3):456-465.
PMID: 31047957 [Pubmed - in process]

10. Letter from Greece.

Respirology. Jul 2019;24(7):700-701.
PMID: 31009956 [Pubmed - in process]

11. Toward clinically applicable biomarkers for asthma: An EAACI position paper.

Allergy. Oct 2019;74(10):1835-1851.
PMID: 30953574 [Pubmed - in process]

+ Εμφάνιση Περίληψης

12. Inflammatory profile in optimally treated patients with adult versus early-onset asthma.

Postgrad Med. Jun 2019;131(5):324-329.
PMID: 30920326 [Pubmed - indexed for MEDLINE]

13. Treatment response in COPD: does FEV

ERJ Open Res. Feb 2019;5(1):
PMID: 30815470 PubMed-not-MEDLINE

+ Εμφάνιση Περίληψης

14. Patients' perspectives on COPD: findings from a social media listening study.

ERJ Open Res. Feb 2019;5(1):
PMID: 30775374 PubMed-not-MEDLINE

+ Εμφάνιση Περίληψης

15. Serum levels of hyaluronic acid are associated with COPD severity and predict survival.

Eur Respir J. Mar 2019;53(3):
PMID: 30705130 [Pubmed - in process]

+ Εμφάνιση Περίληψης

16. Microbiota and asthma: Clinical implications.

Respir Med. 01 2019;146:28-35.
PMID: 30665515 [Pubmed - in process]

17. Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study.

Respir Res. 08 Jan 2019;20(1):4.
PMID: 30621717 [Pubmed - indexed for MEDLINE]

18. Reply to Lan and Shi: Different Background, Short Duration, and Inappropriate Participants May Harm Your Conclusion.

Am J Respir Crit Care Med. 01 02 2019;199(3):390-392.
PMID: 30335471 [Pubmed - indexed for MEDLINE]

19. Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients.

NPJ Prim Care Respir Med. 10 09 2018;28(1):33.
PMID: 30202023 [Pubmed - indexed for MEDLINE]

+ Εμφάνιση Περίληψης

20. Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study.

Int J Chron Obstruct Pulmon Dis. 2018;13:2557-2568.
PMID: 30197512 [Pubmed - indexed for MEDLINE]

188 Αντικείμενα. Σελίδα 1/10
1 2 3 4 5 6 7 8 9 10
 
Developed by LogicOne